MR imaging helps predict recurrence in prostate cancer patients

May 04, 2007

MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return, according to a recent study conducted by radiologists at the University of California-San Francisco.

The study consisted of 74 men with biopsy-proven prostate cancer who underwent endorectal MR imaging of the prostate, said Antonio Westphalen, MD, lead author of the study. Tumor size, stage and extracapsular extension (cancer spread outside the prostate gland capsule) were all recorded.

"The study focused on patients who were treated with radiation therapy, more specifically, external beam radiation therapy, which is the treatment of choice of about one-third of patients with newly diagnosed prostate cancer," said Dr. Westphalen.

After a follow-up of an average 42 months, four patients developed metastases – all four had extracapsular extension seen on MR imaging before treatment, Dr. Westphalen said. Three of them had more than 5mm of extracapsular extension at MR imaging, he said.

"The main goal of our study was to identify features on our imaging that would predict treatment failure, perhaps allowing for a more conscientious decision ahead of time. We found that a subset of patients who presented with imaging signs of extracapsular extension prior to radiation were more likely to develop metastases in the future," said Dr. Westphalen.

The full results of the study will be presented on Tuesday, May 8, 2007 during the American Roentgen Ray Society Annual Meeting in Orlando, FL.

Source: American Roentgen Ray Society

Explore further: High radiotherapy dose improves prospects for children with brain cancer

Related Stories

Potential new breathalyzer for lung cancer screening

Feb 18, 2015

Researchers from Chongqing University in China have developed a high sensitive fluorescence-based sensor device that can rapidly identify cancer related volatile organic compounds—biomarkers found exclusively in the exhaled ...

Molecular imaging 'probes' pinpoint prostate cancer

Jun 07, 2010

Molecular imaging has a powerful new weapon in the fight against prostate cancer. Research introduced at SNM's 57th Annual Meeting demonstrates how a novel peptide-targeted imaging agent could help clinicians detect a biological ...

Recommended for you

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.